Lupin Pharma partners with Endoceutics to commercialise Intrarosa in Canada

Intrarosa is Endoceutic's flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news